Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.

[1]  Philip Rosenstiel,et al.  Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype , 2011, Proceedings of the National Academy of Sciences.

[2]  R. Ophoff,et al.  Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9 , 2011, Hepatology.

[3]  T. Karlsen,et al.  Deciphering the genetic predisposition to primary sclerosing cholangitis. , 2011, Seminars in liver disease.

[4]  S. Brand,et al.  Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis , 2011, Digestion.

[5]  Dror Berel,et al.  Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. , 2010, Human molecular genetics.

[6]  P. Gregersen,et al.  Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis , 2010, Nature Genetics.

[7]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[8]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[9]  R. Stockley,et al.  Gamma-Glutamyl Transferase: The Silent Partner? , 2010, COPD.

[10]  T. Karlsen,et al.  Update on primary sclerosing cholangitis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[11]  U. Švajger,et al.  C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity , 2010, Cellular Signalling.

[12]  C. Wijmenga,et al.  Genome-wide association analysis in primary sclerosing cholangitis. , 2010, Gastroenterology.

[13]  Ming-Huei Chen,et al.  Genome-wide association meta-analysis for total serum bilirubin levels. , 2009, Human molecular genetics.

[14]  C. Ware,et al.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners , 2009, Seminars in Immunopathology.

[15]  H. Hara,et al.  CARD9 versus CARMA1 in innate and adaptive immunity. , 2009, Trends in immunology.

[16]  M Bruinenberg,et al.  Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling , 2009, Gut.

[17]  Luigi Ferrucci,et al.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. , 2008, American journal of human genetics.

[18]  K. Murphy,et al.  Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator. , 2008, Arthritis and rheumatism.

[19]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[20]  Joseph T. Glessner,et al.  A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene , 2007, Nature.

[21]  A. Bergquist,et al.  Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. , 2007, Gastroenterology.

[22]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[23]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[24]  J. Le Pendu,et al.  Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G-->A and 839T-->C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal. , 2004, The Biochemical journal.

[25]  O. Olerup,et al.  Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[26]  S. M. Henry,et al.  Secretor genotyping for A385T, G428A, C571T, C628T, 685delTGG, G849A, and other mutations from a single PCR , 2000, Transfusion.

[27]  G. Lennon,et al.  Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. , 1995, The Journal of biological chemistry.

[28]  A. Mentis,et al.  ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers , 1991, Epidemiology and Infection.

[29]  A. Chao.  Estimating the population size for capture-recapture data with unequal catchability. , 1987, Biometrics.

[30]  R. Chapman,et al.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.

[31]  Christian Gieger,et al.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci , 2011, Nature Genetics.

[32]  A. Zhernakova,et al.  Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.

[33]  S. Seixas,et al.  Infection-associated FUT2 (Fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies , 2009, Glycoconjugate Journal.

[34]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[35]  D. Keppler,et al.  Transport of leukotriene C4 and structurally related conjugates. , 2002, Vitamins and hormones.

[36]  D. Faith.  Conservation evaluation and phylogenetic diversity , 1992 .